FA
DGX icon

FMA Advisory’s Quest Diagnostics DGX Stock Holding History

FMA Advisory’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$26K Buy
+358
New +$26.4K 0.02% 225
2014
Q1 		– Sell
-10,627
Closed -$569K – 125
2013
Q4 		$569K Sell
10,627
-19
-0.2% -$1.13K 0.23% 106
2013
Q3 		$658K Sell
10,646
-1,015
-9% -$60.8K 0.26% 109
2013
Q2 		$707K Buy
+11,661
New +$695K 0.3% 104

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FMA Advisory's DGX Position: Q2 2015 in Review

FMA Advisory opened a new position in Quest Diagnostics (DGX) in Q2 2015: 358 shares worth $26K. The stake represents 0.02% of the portfolio and ranks #225 among its holdings. This is a return to the name: FMA Advisory previously reported a position in DGX as recently as Q4 2013.

FMA Advisory first reported a position in DGX in Q2 2013 and has held it in 4 quarters since. The position peaked at $707K in Q2 2013. 542 funds tracked by Wall St. Rank hold DGX as of Q2 2015.

  • FMA Advisory held 358 shares of Quest Diagnostics worth $26K as of Q2 2015.
  • Quest Diagnostics was a new FMA Advisory position in Q2 2015.
  • Quest Diagnostics made up 0.02% of FMA Advisory's portfolio in Q2 2015, its #225 holding.
  • FMA Advisory first reported a position in Quest Diagnostics in Q2 2013 and has held it in 4 quarters since.
  • FMA Advisory's Quest Diagnostics position peaked at $707K in Q2 2013.
  • 542 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2015.

Based on FMA Advisory's 13F filing for Q2 2015, filed 17 Dec 2019.